Prognostic Significance of Concurrent Gene Mutations in Intensively Treated Patients with IDH1/2 Mutated AML - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Blood Année : 2019

Prognostic Significance of Concurrent Gene Mutations in Intensively Treated Patients with IDH1/2 Mutated AML

(1) , (2) , (3) , (4) , (5) , (6) , (7) , (8) , (9, 10) , (11) , (12) , (13) , (14) , (15) , (4) , (16, 17) , (18) , (17) , (19, 20) , (21) , (22) , (23) , (4, 24) , (25) , (26) , (27) , (15)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Raphael Itzykson
Jean-Pierre Marolleau
  • Fonction : Auteur
  • PersonId : 887235
  • IdRef : 06981676X
Lionel Ades
  • Fonction : Auteur

Dates et versions

hal-03605008 , version 1 (10-03-2022)

Identifiants

Citer

Jean Valere Malfuson, Cecile Pautas, Juliette Lambert, Nicolas Boissel, Karine Celli-Lebras, et al.. Prognostic Significance of Concurrent Gene Mutations in Intensively Treated Patients with IDH1/2 Mutated AML. Blood, 2019, 134 (1), ⟨10.1182/blood-2019-127082⟩. ⟨hal-03605008⟩
25 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More